Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A newer revision entry (v3.5.5) was added to the study's version history, replacing the previous revision (v3.5.4) and signaling an update to the record metadata.
    Difference
    0.1%
    Check dated 2026-06-08T05:32:14.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a minor site release update. The update does not alter study content or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:45:09.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3. This represents a site release/version change rather than a modification to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-26T13:45:13.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Added a 2026-04-13 entry for Study Status and updated to Revision: v3.5.2, with an accompanying 2026-04-08 entry; removed Revision: v3.5.0.
    Difference
    0.5%
    Check dated 2026-04-19T04:58:16.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Removed the References and Oversight sections from the study record history view.
    Difference
    0.2%
    Check dated 2026-04-11T20:53:19.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added revision 3.5.0 to the history and removed revision 3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T09:08:25.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.